Advances in Colloidal Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 August 2025 | Viewed by 1147
Special Issue Editor
Special Issue Information
Dear Colleagues,
The Pharmaceutics journal is excited to present a Special Issue entitled "Advances in Colloidal Drug Delivery Systems". Colloidal drug delivery systems, including liposomes, nanoparticles, and micelles, are pivotal to enhancing the solubility, stability, and bioavailability of therapeutic agents. These systems offer targeted delivery and controlled release, improving therapeutic outcomes and reducing side effects. The scientific background emphasizes the versatility and adaptability of colloidal carriers in addressing the challenges of traditional drug formulations. This research is crucial for developing innovative solutions that improve patient compliance and treatment efficacy. The aim of this Special Issue is to showcase the latest advancements in the design, synthesis, and application of colloidal systems in drug delivery. Contributions are invited that explore novel materials, formulation strategies, characterization techniques, and clinical applications, providing a comprehensive overview of current trends and future directions in this dynamic field.
I look forward to receiving your contributions.
Dr. Wei Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colloidal drug delivery
- liposomes
- nanoparticles
- micelles
- solubility enhancement
- bioavailability
- targeted delivery
- controlled release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
